D. E. Shaw & Co., Inc. Biotechnology

D. E. Shaw & Co., Inc.

  • $122 Billion
  • Q4 2024

Stock List

Stock Option Type Value Options Held Last Trade Trade History
MRNA
Moderna, Inc.
PUT
$81.5 Million
1.96M
Q4 2024
Added 582.57%
NVO
Novo Nordisk A S
PUT
$52.1 Million
606K
Q4 2024
Added 126.92%
MRNA
Moderna, Inc.
CALL
$27.8 Million
668K
Q4 2024
Added 582.57%
REGN
Regeneron Pharmaceuticals, Inc.
PUT
$27.6 Million
38.8K
Q4 2024
Added 87.89%
REGN
Regeneron Pharmaceuticals, Inc.
CALL
$27.6 Million
38.7K
Q4 2024
Added 87.89%
ARGX
Argenx Se
CALL
$22.8 Million
37K
Q4 2024
Added 183.75%
BNTX
Bio N Tech Se
PUT
$22.7 Million
200K
Q4 2024
Reduced 74.05%
MDGL
Madrigal Pharmaceuticals, Inc.
CALL
$21.5 Million
69.6K
Q4 2024
New holding
NVO
Novo Nordisk A S
CALL
$9.1 Million
106K
Q4 2024
Added 126.92%
ALNY
Alnylam Pharmaceuticals, Inc.
CALL
$5.55 Million
23.6K
Q4 2024
Added 9.26%
BMRN
Biomarin Pharmaceutical Inc
PUT
$3.94 Million
60K
Q4 2024
Added 68.63%
BNTX
Bio N Tech Se
CALL
$3.76 Million
33K
Q4 2024
Reduced 74.05%
BPMC
Blueprint Medicines Corp
CALL
$3.41 Million
39.1K
Q4 2024
Added 41.5%
CRSP
Crispr Therapeutics Ag
CALL
$2.95 Million
74.9K
Q3 2024
Added 4.23%
AXSM
Axsome Therapeutics, Inc.
PUT
$2.67 Million
31.5K
Q4 2024
Added 601.59%
MDGL
Madrigal Pharmaceuticals, Inc.
PUT
$2.62 Million
8.5K
Q4 2024
New holding
VKTX
Viking Therapeutics, Inc.
CALL
$2.15 Million
53.5K
Q4 2024
Reduced 77.6%
AXSM
Axsome Therapeutics, Inc.
CALL
$2.06 Million
24.3K
Q4 2024
Added 601.59%
TGTX
Tg Therapeutics, Inc.
CALL
$1.68 Million
55.9K
Q4 2024
Reduced 57.32%
NVAX
Novavax Inc
CALL
$1.31 Million
164K
Q4 2024
Reduced 2.47%
ALNY
Alnylam Pharmaceuticals, Inc.
PUT
$1.08 Million
4.6K
Q4 2024
Added 9.26%
APLS
Apellis Pharmaceuticals, Inc.
CALL
$1.01 Million
31.7K
Q4 2024
New holding
APLS
Apellis Pharmaceuticals, Inc.
PUT
$989,000
31K
Q4 2024
New holding
SMMT
Summit Therapeutics Inc.
CALL
$981,000
55K
Q4 2024
Reduced 91.04%
NTLA
Intellia Therapeutics, Inc.
PUT
$752,000
64.5K
Q4 2024
Added 173.48%
INSM
Insmed Inc
PUT
$690,000
10K
Q4 2024
Added 662.4%
ASND
Ascendis Pharma A/S
CALL
$688,000
5K
Q4 2024
Reduced 57.98%
BPMC
Blueprint Medicines Corp
PUT
$575,000
6.6K
Q4 2024
Added 41.5%
UTHR
United Therapeutics Corp
CALL
$529,000
1.5K
Q4 2024
Reduced 16.03%
LEGN
Legend Biotech Corp
PUT
$296,000
9.1K
Q1 2024
Reduced 75.95%
RVNC
Revance Therapeutics, Inc.
CALL
$77,000
30K
Q4 2024
Reduced 29.23%
Filter Shares Options
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email